drugset / Trial / NCT01767493
Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the feasibility of \[18F\]Florbetapir positron emission tomography (PET) for assessment of demyelination in the patients with relapsing remitting multiple sclerosis.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | florbetapir F 18 | Diagnostic / imaging agent | — | — |